When pricing OTC contracts in the presence of additional risk factors and costs, such as credit funding collateral starting “clean price” is modified additively by valuation adjustments (XVAs) that account for each factor or cost isolation, while seemingly ignoring combined effects. Instead, costs can be jointly accounted ab initio mechanism at level cash flows, this “adjusted flow" approach le...